https://www.mympnteam.com/treatments/inrebic
Inrebic (Fedratinib) for Myeloproliferative Neoplasms | myMPNteam
Overview Inrebic is a prescription drug approved by the U.S. Food and Drug Administration...
myeloproliferative neoplasmsinrebicfedratinib
https://www.countstar.com/publication/fedratinib-attenuates-bleomycin-induced-pulmonary-fibrosis-via-the-jak2-stat3-and-tgf-1-signaling-pathway
Fedratinib Attenuates Bleomycin-Induced | Countstar
In vitro studies have shown that Fed attenuates TGF-β1- and IL-6-induced myofibroblast activation. Countstar supported the reported cell analysis.
fedratinibattenuatesbleomycininduced
https://pharsight.greyb.com/ingredient/fedratinib-hydrochloride-patent-expiration
Drug Patents containing Fedratinib Hydrochloride
Find out details of Fedratinib Hydrochloride patent expiration, the company that first launched it, other drugs containing it as an active ingredient, and...
drug patentsfedratinib hydrochloridecontaining